These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 19506357

  • 21. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 22. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
    Castaman G, Bertoncello K, Bernardi M, Eikenboom JC, Budde U, Rodeghiero F.
    Am J Hematol; 2007 May; 82(5):376-80. PubMed ID: 17109387
    [Abstract] [Full Text] [Related]

  • 23. Molecular genetics of type 2 von Willebrand disease.
    Fressinaud E, Mazurier C, Meyer D.
    Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
    [Abstract] [Full Text] [Related]

  • 24. L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.
    Kashiwagi T, Matsushita T, Ito Y, Hirashima K, Sanda N, Fujimori Y, Yamada T, Okumura K, Takagi A, Murate T, Katsumi A, Takamatsu J, Yamamoto K, Naoe T, Kojima T.
    Haemophilia; 2008 May; 14(3):556-63. PubMed ID: 18397285
    [Abstract] [Full Text] [Related]

  • 25. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
    Keeney S, Cumming A, Hay C.
    Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
    [Abstract] [Full Text] [Related]

  • 26. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ, van Vliet HH, Berneman Z, Schroyens W, Gadisseur A.
    Acta Haematol; 2009 Nov; 121(2-3):167-76. PubMed ID: 19506363
    [Abstract] [Full Text] [Related]

  • 27. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
    Gaucher C, de Romeuf C, Rauïs-Morret M, Corazza F, Fondu P, Mazurier C.
    Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB.
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [Abstract] [Full Text] [Related]

  • 29. Management of inherited von Willebrand disease in 2007.
    Federici AB, Mannucci PM.
    Ann Med; 2007 Sep; 39(5):346-58. PubMed ID: 17701477
    [Abstract] [Full Text] [Related]

  • 30. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.
    Meyer D, Fressinaud E, Hilbert L, Ribba AS, Lavergne JM, Mazurier C.
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):349-64. PubMed ID: 11686104
    [Abstract] [Full Text] [Related]

  • 31. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
    Wang Y, Zhang J, Wan H.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):117-9. PubMed ID: 11601234
    [Abstract] [Full Text] [Related]

  • 32. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
    Penas N, Pérez-Rodríguez A, Torea JH, Lourés E, Noya MS, López-Fernández MF, Batlle J.
    Am J Hematol; 2005 Nov; 80(3):188-96. PubMed ID: 16247740
    [Abstract] [Full Text] [Related]

  • 33. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
    Hilbert L, Nurden P, Caron C, Nurden AT, Goudemand J, Meyer D, Fressinaud E, Mazurier C, INSERM Network on Molecular Abnormalities in von Willebrand Disease.
    Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269
    [Abstract] [Full Text] [Related]

  • 34. Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.
    Schneppenheim R, Budde U, Obser T, Brassard J, Mainusch K, Ruggeri ZM, Schneppenheim S, Schwaab R, Oldenburg J.
    Blood; 2001 Apr 01; 97(7):2059-66. PubMed ID: 11264172
    [Abstract] [Full Text] [Related]

  • 35. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
    Hilbert L, Jenkins PV, Gaucher C, Meriane E, Collins PW, Pasi KJ, Mazurier C.
    Thromb Haemost; 2000 Aug 01; 84(2):188-94. PubMed ID: 10959688
    [Abstract] [Full Text] [Related]

  • 36. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A.
    Haematologia (Budap); 1994 Aug 01; 26(2):97-109. PubMed ID: 7890268
    [Abstract] [Full Text] [Related]

  • 37. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1.
    Schneppenheim R, Budde U, Krey S, Drewke E, Bergmann F, Lechler E, Oldenburg J, Schwaab R.
    Thromb Haemost; 1996 Oct 01; 76(4):598-602. PubMed ID: 8903002
    [Abstract] [Full Text] [Related]

  • 38. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H, Driesen J, Pavlova A, Biswas A, Hertfelder HJ, Oldenburg J.
    Thromb Haemost; 2012 Oct 01; 108(4):662-71. PubMed ID: 22871923
    [Abstract] [Full Text] [Related]

  • 39. Understanding von Willebrand's disease from gene defects to the patients.
    Zhang Z, Blombäck M, Anvret M.
    J Intern Med Suppl; 1997 Oct 01; 740():115-9. PubMed ID: 9350192
    [Abstract] [Full Text] [Related]

  • 40. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.
    Thromb Res; 2009 Apr 01; 123(6):862-8. PubMed ID: 19064279
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.